Stay updated on Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T21:07:56.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T20:10:13.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    A minor site revision tag (Revision: v3.4.2) was added, and the previous government funding notice about updates and operations was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:39:51.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH operations was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-03T23:48:32.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added a Show glossary option, added Last Update Submitted that Met QC Criteria, added No FEAR Act Data, and updated Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, removed No FEAR Act data, and removed Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T23:57:27.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 was removed; there are no changes to the study details, eligibility criteria, locations, or primary/secondary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:46:12.000Z thumbnail image

Stay in the know with updates to Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.